Trogocytosis represents a novel mechanism of action of daratumumab in multiple myeloma

Lignende værker

• Daratumumab for the Treatment of Multiple Myeloma
  af: Plesner, Torben, et al.
  Udgivet: (2018)
• CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance
  af: van de Donk, Niels W.C.J., et al.
  Udgivet: (2018)
• Daratumumab for the Treatment of Multiple Myeloma
  af: Torben Plesner, et al.
  Udgivet: (2018-06-01)
• High‐Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action
  af: Adams, Homer C., et al.
  Udgivet: (2018)
• Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment
  af: Frerichs, Kristine A., et al.
  Udgivet: (2019)